Medroxyprogesterone Acetate Plus Metformin for Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Endometrial Carcinoma: Trial Protocol for a Prospective, Randomised, Open, Blinded-Endpoint Design, Dose-Response Trial (FELICIA Trial)
BMJ Open - United Kingdom
doi 10.1136/bmjopen-2019-035416
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 1, 2020
Authors
Publisher
BMJ